CGP-53353 (Standard)

Overview

CGP-53353 (Standard) is the analytical standard of CGP-53353 ( HY-108600 ). This product is intended for research and analytical applications. CGP-53353 (DAPH-7) is an potent PKC inhibitor with IC 50 s of 0.41 μM and 3.8 μM for PKCβII and PKCβI, respectively. CGP-53353 can inhibit glucose-induced cell proliferation and DNA synthesis in AoSMC and A10 cells. CGP-53353 can be used for researching atherosclerosis of diabetic patients.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > PKC | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-108600R
• CAS No.: 145915-60-2
• Molecular Formula: C20H13F2N3O2
• Molecular Weight: 365.33
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source